Conexeu Sciences Inc.

BiotechnologyBiotechnologyTissue RegenerationReg CF

📍 Reno, NV, USA

StreetZero Signal 63

Be the first to signal interest

About Conexeu Sciences Inc.

Conexeu Sciences Inc. is a biotechnology company based in Reno, Nevada, focused on advancing tissue regeneration through its patented collagen platform with potential applications in wound care, veterinary medicine, and 3D bioprinting. The company completed a $5 million Regulation Crowdfunding financing via the Equifund platform in under two weeks. It is listed on Nasdaq under the ticker CNXU and has conducted multiple smaller raises throughout 2026.

LATEST FUNDINGPrivate Placement

$31K

Announced 2026-09-29

TOTAL RAISED$12.22M

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Conexeu Sciences Inc..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS

EMPLOYEES—

FOUNDED—

HQReno, NV, USA

Industry

Biotechnology

Investors

Equifund

Key highlights

Completed $5M Reg CF financing in less than two weeks through Equifund platform.
Patented collagen platform targeting wound care, veterinary, and 3D bioprinting markets.
Listed on Nasdaq as CNXU with an IPO round of $37.92M.
Multiple small raises documented in 2026 totaling over $12M in disclosed funding.

Ask StreetZero about Conexeu Sciences Inc.

Put our AI to work on this deal.

What is Conexeu Sciences Inc.'s value proposition?Who are Conexeu Sciences Inc.'s competitors?Why does this raise matter?Summarize Conexeu Sciences Inc. for an investor.

Similar companies

Other Biotechnology deals, ranked by Signal.

Caspian Therapeutics, Inc.

$50.0M

GENHEALTH, INC.

$16.5M

Typewriter Therapeutics, Inc.

$56.3M

Vetmab Biosciences, Inc.

$11.4M

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.